 |
|
|
|
|
Vitamin C Shows Promise as Cancer Treatment
|
| | | | Related Healthscout Videos | |
|
Page: << Prev | 1 | 2 It's not clear why some tumors are immune to the treatment and others are not, Levine said, although normal cells are unharmed by the therapy.
According to the researchers, it's possible to intravenously boost levels of vitamin C in humans to the levels used in the mice.
But Levine cautioned that the treatment isn't ready for prime time with humans. "Should patients with any kind of tumor go out and get IV ascorbate [vitamin C]? That's not the message here," he said.
Text Continues Below
Instead, he said, the study shows the need for more research.
Dr. Len Lichtenfeld, deputy chief medical officer of the American Cancer Society, said the research is interesting but not yet proven.
"Like so many things that are intriguing or appear to be promising, there appears to be a long way to go from the theory in the lab to the practical application in the clinic."
More information
To learn more about vitamin C, visit the U.S. National Institutes of Health.
Page: << Prev | 1 | 2
|
Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 8/5/2008
|
|
SOURCES: Mark Levine, M.D., chief, Molecular and Clinical Nutrition Section, and senior staff physician, U.S. National Institutes of Health, Bethesda, Md.; Len Lichtenfeld, M.D., deputy chief medical officer, American Cancer Society, Atlanta; Aug. 4-8, 2008, Proceedings of the National Academy of Sciences
|
.gif)
